Permal Deo | Prostate Cancer | Best Researcher Award

Published on by Oncology

Dr. Permal Deo | Prostate Cancer | Best Researcher Award

Senior Lecturer | Clinical and Health Sciences, University of South Australia | Australia

Dr. Permal Deo is a distinguished food scientist and academic leader renowned for his contributions to nutrition, food biochemistry, and public health research. He holds a PhD in Food Biochemistry from Queen’s University Belfast, UK, where his doctoral work investigated the effects of food-derived advanced glycation end-products (AGEs) on oxidative stress and receptor activity in human cell lines. Complementing this, he earned a Master of Applied Science and Postgraduate Diploma from The University of Queensland, Australia, and a Bachelor of Science from The University of the South Pacific, Fiji. With over two decades of academic, research, and industry experience, Dr. Deo’s expertise encompasses food microbiology, food processing, functional foods, and the molecular pathways linking type 2 diabetes and Alzheimer’s disease. His research emphasizes the bioactivity of natural plant compounds and nutraceuticals in combating oxidative stress and inflammation, as well as the antimicrobial and food safety applications of electrochemically activated solutions. An accomplished mentor and research leader, he has supervised numerous postgraduate students and attracted more than AUD 2.5 million in competitive funding from prestigious bodies including the Australian Research Council, Diabetes Australia, and Horticulture Innovation. His extensive collaborations with institutions such as CSIRO, Monash University, and the University of Adelaide have advanced understanding in genome stability, indigenous food systems, and sustainable nutrition technologies. Widely recognized for his scholarly impact and leadership, Dr. Deo has presented at global scientific conferences and published influential studies in leading journals. His enduring scientific legacy is reflected through 944 citations, 57 documents, and an h-index of 19, underscoring his influential role in advancing the frontiers of food biochemistry, nutritional science, and biomedical innovation.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

1. Snelson, M., Tan, S. M., Clarke, R. E., De Pasquale, C., Thallas-Bonke, V., Deo, P., … & Coughlan, M. T. (2021). Processed foods drive intestinal barrier permeability and microvascular diseases. Science Advances, 7(14), eabe4841. Cited by: 148

2. Sim, D. P., Khazandi, M., Chan, W. Y., Deo, P., & Trott, D. J. (2019). Antimicrobial activity of thyme oil, oregano oil, thymol and carvacrol against sensitive and resistant microbial isolates from dogs with otitis externa. Veterinary Dermatology. Cited by: 106

3. Deo, P., Hewawasam, E., Karakoulakis, A., Claudie, D. J., Nelson, R., & Vemulpad, S. (2016). In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE), and digestive enzymes linked to diabetes. BMC Complementary and Alternative Medicine, 16(1), 435. Cited by: 61

4. Bergamin, A., Mantzioris, E., Cross, G., Deo, P., Garg, S., & Hill, A. M. (2019). Nutraceuticals: Reviewing their role in chronic disease prevention and management. Pharmaceutical Medicine, 33(4), 291–309. Cited by: 60

5. Fenech, M., Knasmueller, S., Knudsen, L. E., Kirsch-Volders, M., Deo, P., … & Bonassi, S. (2021). “Micronuclei and Disease” special issue: Aims, scope, and synthesis of outcomes. Mutation Research/Reviews in Mutation Research, 788, 108384. Cited by: 54

6. Ferro, S., Amorico, T., & Deo, P. (2018). Role of food sanitising treatments in inducing the ‘viable but nonculturable’ state of microorganisms. Food Control, 91, 321–329. Cited by: 54

Rami Ahmad | Cancer Therapy | Best Researcher Award

Published on by Oncology

Prof. Dr. Rami Ahmad | Cancer Therapy | Best Researcher Award

Senior Researcher | Czech Education and Scientific Network | Czech Republic

Prof. Dr. Rami Ahmad El-Nabulsi is a distinguished theoretical physicist and applied mathematician whose research bridges nonlinear quantum dynamics, fractal mechanics, plasma and solid-state physics, and advanced mathematical modeling. Holding a PhD in Particle and Mathematical Physics from AMU, along with postgraduate diplomas in Plasma Physics and degrees in Physics at both master’s and bachelor’s levels, he has built a prolific career combining theoretical rigor with computational innovation. He is currently affiliated with the Center of Excellence in Quantum Technology, Faculty of Engineering, and the Quantum-Atom Optics Laboratory at Chiang Mai University, Thailand, as well as with the University of South Bohemia and the Department of Optical Networks CESNET in the Czech Republic. Prof. El-Nabulsi’s research interests encompass geometrical and quantum dynamics, nonlinear systems, chaos and bifurcations, general relativity, quantum field theory, and the application of fractional and fractal calculus to complex systems in engineering, astrophysics, and materials science. His expertise extends to advanced computational modeling, partial differential equations, stochastic systems, and numerical simulations. He has received multiple international honors, including the Outstanding Scientist Research Award and the Lifetime Achievement Award. A reviewer for more than 250 scientific journals and an editorial board member in over 40 peer-reviewed publications, he has authored more than 390 research articles in high-impact international journals and is frequently invited as an honorary speaker at global conferences. Prof. El-Nabulsi’s academic dedication, multidisciplinary approach, and sustained research excellence continue to shape theoretical and applied physics worldwide. His scholarly impact is reflected in 4,873 citations, 277 documents, and an h-index of 35, underscoring his influential role in advancing modern fractal physics and nonlinear dynamical systems research.

Profiles: Google Scholar | Scopus | ORCID 

Featured Publications

1. El-Nabulsi, R. A., & Anukool, W. (2025). Chaotic and fractal maps in higher-order derivative dynamical systems. Frontiers in Physics, 12, 1529644. Cited by: 8

2. El-Nabulsi, R. A., & Anukool, W. (2025). Qualitative financial modelling in fractal dimensions. Financial Innovation, 11, 42. Cited by: 6

3. El-Nabulsi, R. A. (2025). A fractional model to study soliton in presence of charged space debris at low-Earth orbital plasma region. IEEE Transactions on Plasma Science, 52(9), 4671–4693. Cited by: 4

4. El-Nabulsi, R. A., & Golmankhaneh, A. K. (2025). Propagation of waves in fractal spaces. Waves in Random and Complex Media. Cited by: 4

5. El-Nabulsi, R. A., & Anukool, W. (2025). Vlasov equation, waves and dispersion relations in fractal dimensions: Landau damping and the toroidal ion temperature gradient instability problem. Waves in Random and Complex Media. Cited by: 14

6. El-Nabulsi, R. A. (2024). Transition from circular to spiral waves and from Mexican hat to upside-down Mexican hat-solutions: The cases of local and nonlocal λ–ω reaction–diffusion–convection fractal systems with variable coefficients. Chaos, Solitons & Fractals, 189, 115737. Cited by: 3

7. El-Nabulsi, R. A. (2024). Modelling nematic liquid crystal in fractal dimensions. Medicine in Novel Technology and Devices, 24, 100334. Cited by: 7

Shijia Lu | Medicine | Best Researcher Award

Published on by Oncology

Mr. Shijia Lu | Medicine | Best Researcher Award

Sanquan College of Xinxiang Medical University | China

AUTHOR PROFILE

ORCID ID

🏥MR. SHIJIA LU: ACADEMIC AND PROFESSIONAL PROFILE

🎓EARLY ACADEMIC PURSUITS

Mr. Shijia Lu embarked on his academic journey with a Bachelor’s degree in Biotechnology from Sanquan College of Xinxiang Medical University. Demonstrating early interest in tumor-targeted therapy, he quickly advanced into translational research and academic publishing. His undergraduate years were marked by robust interdisciplinary learning, laying the foundation for integrating bioinformatics, network pharmacology, and molecular simulations in cancer research.

🩺PROFESSIONAL ENDEAVORS

Currently serving as the Associate Editor of Guide to Biomedical Research Tools, Mr. Lu also holds student membership in the Chinese Society for Biotechnology. His roles extend beyond editorial to include project leadership, drug discovery, and computational biology. He has successfully led and contributed to university-level and provincial scientific projects, focusing on innovative strategies to combat cancer resistance.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON MEDICINE

Mr. Lu’s research is centered on tumor-targeted therapies, especially those overcoming PCNA-mediated resistance. Notable among his contributions:

  • Invented the “Structural Coupling – Functional Synergy” strategy, bridging natural product EGCG and synthetic inhibitors for synergistic effects.

  • Designed AL-1/AL-3, novel dual-ligand inhibitors tackling L47V mutation resistance in cancer cells.

  • Engaged in multi-omics-driven screening for anti-cancer components in natural sources such as pomegranate peel.
    His integrative research style blends wet-lab validation with computational simulations (AutoDock Vina, Cytoscape, ESM-Fold), setting a new paradigm in anti-cancer drug design.

🌍IMPACT AND INFLUENCE

Lu’s research has received national-level recognition, influencing the development of next-generation PCNA inhibitors. His PCNA-targeted strategy, featured in In Silico Research in Biomedicine, provides a blueprint for multi-target drug designs. Through editorial and competition platforms, he has advocated bioinformatics integration in biomedical research, inspiring peer groups and junior researchers in China’s academic circuits.

🏆 ACCOLADES AND RECOGNITION

Awards:
🥈 Second Prize, National College Students’ Innovation and Entrepreneurship Competition (Medical Health Category)
🏅 Three national-level research competition awards
🌍 Two provincial-level foreign language translation awards

🏆LEGACY AND FUTURE CONTRIBUTIONS

Mr. Lu’s pioneering research in drug resistance mechanisms, particularly in PCNA-targeted therapy, promises long-term value to precision oncology. His interdisciplinary approach—linking structural biology, network pharmacology, and bioinformatics—will likely influence future drug discovery pipelines, especially for hard-to-treat tumors. He is poised to emerge as a thought leader in the next generation of biomedical researchers.

🧬CONCLUSION

With a dynamic blend of technical mastery, scientific curiosity, and a vision for impact, Mr. Shijia Lu is a rising biomedical innovator. His work addresses one of the greatest challenges in medicine today—anti-cancer drug resistance—while his leadership in academia and publishing continues to foster new frontiers in biotechnology and translational research.

📊🔬NOTABLE PUBLICATION:

Design and anti-drug resistance research of novel PCNA-targeted inhibitors based on network pharmacology and molecular docking

Authors: Shijia Lu; YiRan Zhen; Jinwen Sima; Jinle Wang; Qihao Zhu; Miaoyan Han; Mengdan Sang; Xuejiao Li; Bing Zhang; Zihan Wang; et al.

Journal: In Silico Research in Biomedicine

Year: 2025